Lexington, MA – According to filings with the U.S. Securities and Exchange Commission, Fractyl Health is raising $99,999,949.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Harith Rajagopalan played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Fractyl Health
Fractyl aims to bring curative therapies to the large populations of patients with metabolic disease. Fractals appear all throughout nature. They are self-repeating patterns in plants, animals, rivers, mountains, coastlines, and even clouds all seemingly complex structures that are, in fact, fundamentally quite simple at their base. To us, fractals represent the inherent regenerative nature of biology, and it is this concept of regeneration that inspires us as we develop therapeutics that address seemingly complex metabolic diseases from their inherently simple roots in the intestines. With our innovative products, our goal is to truly shift the treatment paradigm for patients with metabolic disease by focusing on their root cause in the intestine to provide meaningful, transformative, benefits to restore patient health from metabolic diseases.

To learn more about Fractyl Health, visit http://www.fractyl.com/

Contact:
Harith Rajagopalan, Chief Executive Officer
781-902-8800
harith@fractyl.com
https://www.linkedin.com/in/harith-rajagopalan-fractyl/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved